Blood flow imaging of the brain: 50 Years experience

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 17, Issue 4, 2005, Pages 441-446

  Taber, Katherine H ^a,b   Black, Kevin J ^c   Hurley, Robin A ^a,b,d,e  

^a Education and Clinical Center   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTORADIOGRAPHY; BRAIN BLOOD FLOW; BRAIN FUNCTION; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 29044435445     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.17.4.441     Document Type: Review

References (45)

1. Landau WM, Freygang WH Jr, Roland LP, et al: The local circulation of the living brain: values in the unanesthetized and anesthetized cat. Trans Am Neurol Assoc 1955; 80:125-129
2. Nutt R: The history of positron emission tomography. Mol Imaging Biol 2002; 4:11-26
3. Mukherjee P, Kang HC, Videen TO, et al: Measurement of cerebral blood flow in chronic carotid occlusive disease: Comparison of dynamic susceptibility contrast perfusion MR imaging with positron emission tomography. Am J Neuroradiol 2003; 24:862-871
4. Kety SS: Measurement of local blood flow by the exchange of an inert, diffusible substance. Methods Med Res 1960; 8:228-236
5. Small SA: Quantifying cerebral blood flow: regional regulation with global implications. J Clin Invest 2004; 114:1046-1048
6. Kety SS: Measurement of local contribution within the brain by means of inert, diffusible tracers: examination of the theory, assumptions and possible sources of error. Acta Neurol Scand Suppl 1965; 14:20-23
7. Reivich M, Jehle J, Sokoloff L, et al: Measurement of regional cerebral blood flow with antipyrine-14C in awake cats. J Applied Physiol 1969; 27:296-300
8. Ullberg S, Larsson B, Tjälve, et al: Autoradiography. 1982; 55-108
9. Raichle ME: Behind the scenes of functional brain imaging: A historical and physiological perspective. Proc Natl Acad Sci 1998; 95:765-772
10. Ginsberg MD, Lockwood AH, Busto R, et al: A simplified in vivo autoradiographic strategy for the determination of regional cerebral blood flow by positron emission tomography: Theoretical considerations and validation studies in the rat. J Cereb Blood Flow Metab 1982; 2:89-98
11. Herscovitch P, Markham J, Raichle ME: Brain blood flow measurement with intravenous H215O. I: Theory and error analysis. J Nucl Med 1983; 24:782-789
12. Raichle ME, Martin W, Herscovitch P, et al: Brain blood flow measured with intravenous H215O. II: Implementation and validation. J Nucl Med 1983; 24:790-798
13. Ingvar DH: History of brain imaging in psychiatry. Dement Geriatr Cogn Disord 1997; 8:66-72
14. Maurer AH: Nuclear medicine: SPECT comparisons to PET. Radiol Clin North Am 1988; 26:1059-1074
15. Jamieson DJ, Alavi A, Jolles P, et al: Positron emission tomography in the investigation of central nervous system disorders. Radiol Clin North Am 1988; 26:1075-1088
16. Fox PT, Perlmutter JS, Raichle ME: A stereotactic method of anatomical localization for positron emission tomography. J Comput Assist Tomogr 1985; 9:141-153
17. Perlmutter JS, Herscovitch P, Powers WJ, et al: Standardized mean regional method for calculating global positron emission tomographic measurements. J Cereb Blood Flow Metab 1985; 5:476-480
18. Ball MJ, Hachinski V, Fox A: A new definition of Alzheimer's disease: a hippocampal dementia. Lancet 1985; 14-16
19. Frankle WG, Laruelle M: Neuroreceptor imaging in psychiatric disorders. Ann Nucl Med 2002; 16:437-446
20. Warwick JM: Imaging of brain function using SPECT. Metab Brain Dis 2004; 19:113-123
21. Lingford-Hughes AR: Human brain imaging and substance abuse. Curr Opin Pharmacol 2005; 5:42-46
22. Parsey RV, Mann JJ: Applications of positron emission tomography in psychiatry. Semin Nucl Med 2003; 33:129-135
23. Newberg AB, Alavi A: The role of PET imaging in the management of patients with central nervous system disorders. Radiol Clin North Am 2005; 43:49-65
24. Camargo EE: Brain SPECT in neurology and psychiatry. J Nucl Med 2001; 42:611-623
25. Gupta A, Elheis M, Pansari K: Imaging in psychiatric illness. Int J Clin Pract 2004; 58:850-858
26. Catafau AM: Brain SPECT in clinical practice, Part I: Perfusion. J Nucl Med 2001; 42:259-271
27. Dougall NJ, Bruggink S, Ebmeier KP: Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia. Am J Geriatr Psychiatry 2004; 12:554-570
28. Trollor JN, Sachdev PS, Haindl W, et al: Regional cerebral blood flow deficits in mild Alzheimer's disease using high resolution single photon emission computerized tomography. Psychiatry Clin Neurosci 2005; 59:280-290
29. Cabranes JA, De Juan R, Encinas M, et al: Relevance of functional neuroimaging in the progression of mild cognitive impairment. Neurol Res 2004; 26:496-501
30. Ceravolo R, Volterrani D, Tognoni G, et al: Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer disease. Clin Neuropharmacol 2004; 27:166-170
31. Tanaka M, Namiki C, Thuy DH, et al: Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer's disease. J Neurol Sci 2004; 225:135-141
32. Henry TR, Van Heertum RL: Positron emission tomography and single photon emission computed tomography in epilepsy care. Semin Nucl Med 2003; 33:88-104
33. Van Paesschen W: Ictal SPECT. Epilepsia 2004; 45:35-40
34. Hurley RA, Taber KH, Zhang J, et al: Neuropsychiatric presentation of multiple sclerosis. J Neuropsychiatry Clin Neurosci 1999; 11:5-7
35. Abu-Judeh HH, Parker R, Singh M, et al: SPECT brain perfusion imaging in mild traumatic brain injury without loss of consciousness and normal computed tomography. Nucl Med Commun 1999; 20:505-510
36. Anderson KE, Taber KH, Hurley RA: Functional imaging. 2005; 107-133
37. Miles KA: Brain perfusion: computed tomography applications. Neuroradiology 2004; 46:194-200
38. Latchaw RE: Cerebral perfusion imaging in acute stroke. J Vasc Interv Radiol 2004; 15:S29-S46
39. Sunshine JL: CT, MR imaging, and MR angiography in the evaluation of patients with acute stroke. J Vasc Interv Radiol 2004; 15:S47-S55
40. Levy EI, Yonas H: Xenon-enhanced computed tomography: Technique and clinical applications. 2005; 259-272
41. Jackson A: Analysis of dynamic contrast enhanced MRI. Br J Radiol 2004; 77:S154-S166
42. Grandin CB, Bol A, Smith AM, et al: Absolute CBF and CBV measurements by MRI bolus tracking before and after acetazolamine challenge: repeatability and comparison with PET in humans. Neuroimage 2005; 26:525-535
43. Ge Y, Law M, Johnson G, et al: Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: Characterizing hemodynamic impairment and inflammatory activity. Am J Neuroradiol 2005; 26:1539-1547
44. Detre JA, Alsop DC: Arterial spin labeled perfusion magnetic resonance imaging. 2005; 323-331
45. Reeves D, Mills MJ, Billick SB, et al: Limitations of brain imaging in forensic psychiatry. J Am Acad Psychiatry Law 2003; 31:89-96